Rankings
▼
Calendar
INVA Q2 2016 Earnings — Innoviva, Inc. Revenue & Financial Results | Market Cap Arena
INVA
Innoviva, Inc.
$1B
Q2 2016 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$32M
Gross Profit
$32M
98.9% margin
Operating Income
$26M
79.7% margin
Net Income
$15M
45.0% margin
EPS (Diluted)
$0.13
QoQ Revenue Growth
+34.3%
Cash Flow
Operating Cash Flow
$12M
Free Cash Flow
$12M
Stock-Based Comp.
$3M
Balance Sheet
Total Assets
$378M
Total Liabilities
$741M
Stockholders' Equity
-$363M
Cash & Equivalents
$113M
← FY 2016
All Quarters
Q3 2016 →